International Clinical Trials Day 2026
Each year on May 20, International Clinical Trials Day recognizes the people and partnerships that make clinical trials possible. This year, Clinical Trials Ontario is marking International Clinical Trials Day by thanking members of Ontario’s clinical trials community for their continued efforts to strengthen and grow the clinical trials environment — helping bring more and […]
2024-2025 Annual Report: Ontario Trials, Canadian Strength
Joint message from Raphael Hofstein, Board Chair and Susan Marlin, President & CEO Clinical trials are where science transforms to care, and Ontario has built the conditions for that connection to thrive. With world-class hospitals and research institutes, diverse communities, engaged patient partners, streamlined processes, and strong industry collaboration, Ontario is home to a thriving life […]
Ontario’s Universal Agreement for Clinical Trials: New Partners, New Version
One Year Later In the fall of 2024, Ontario made history by launching a universal agreement for clinical trials (known as the UACT or the “U-ACT”), which serves as a pre-negotiated contract between research institutions and sponsors for industry-funded clinical trials. Led by the Ontario Leadership Table for Clinical Trials and Clinical Trials Ontario (CTO), […]
New Universal Agreement for Clinical Trials Fuels Efficient Start-Up Times in Ontario
Ontario has taken a pioneering step to accelerate the initiation of clinical trials with a new Universal Agreement for Clinical Trials (UACT) for Ontario. Developed by Clinical Trials Ontario (CTO) and the Ontario Leadership Table for Clinical Trials, the UACT is a contract with non-negotiable language that aims to accelerate trial start-up timelines, improve access […]
CanReview Selected to Build Pan-Canadian Single Research Ethics Board Review Process
The Accelerating Clinical Trials (ACT) consortium, through an independent, international review panel, has selected CanReview to set up, initiate, and conduct a pan-Canadian single REB review and approval process with strict timelines. Currently, researchers who wish to conduct a multi-centre randomized controlled trial (RCT) across Canada are required to get multiple research ethics board (REB) approvals […]
Ontario Announces Support for Clinical Trials in Phase II of Province’s Life Sciences Strategy
The Government of Ontario has announced new investments in the province’s thriving life sciences sector, including funding that will strengthen Ontario’s clinical trials environment. Unveiled today, the next phase of Ontario’s life sciences strategy commits an additional $146 million in support of tools and programs that will help establish Ontario as a global biomanufacturing and […]